Back to top
more

Teladoc Health, Inc. (TDOC)

(Delayed Data from NYSE)

$155.39 USD

155.39
1,632,078

-0.92 (-0.59%)

Updated Jun 21, 2021 04:00 PM ET

After-Market: $155.43 +0.04 (0.03%) 7:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 28% (182 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for TDOC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Teladoc Health, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 787 517 479 122 66
Receivables 169 57 44 27 14
Notes Receivable 0 0 0 0 0
Inventories 57 0 0 0 0
Other Current Assets 47 14 11 7 3
Total Current Assets 1,060 588 533 156 83
Net Property & Equipment 29 10 10 9 7
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 16,602 972 985 658 213
Deposits & Other Assets 18 7 1 1 0
Total Assets 17,755 1,603 1,529 824 304
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 46 9 8 4 2
Current Portion Long-Term Debt 43 0 0 0 2
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 178 81 55 36 17
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 66 0 0 0 0
Total Current Liabilities 333 90 62 40 21
Mortgages 0 0 0 0 0
Deferred Taxes/Income 105 22 32 13 2
Convertible Debt 1,380 440 415 207 0
Long-Term Debt 0 0 0 0 42
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 12 12 6 5 8
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,871 589 516 265 73
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 16,858 1,539 1,435 866 436
Retained Earnings -993 -508 -409 -312 -205
Other Equity 19 -17 -13 4 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 15,884 1,014 1,013 559 231
Total Liabilities & Shareholder's Equity 17,755 1,603 1,529 824 304
Total Common Equity 15,884 1,014 1,013 559 231
Shares Outstanding 144.96 72.38 70.10 57.00 54.00
Book Value Per Share 109.57 14.01 14.45 9.81 4.28

Fiscal Year End for Teladoc Health, Inc. falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 723 787 1,190 1,312 511
Receivables 178 169 86 77 71
Notes Receivable 0 0 0 0 0
Inventories 58 57 12 0 0
Other Current Assets 73 47 22 14 15
Total Current Assets 1,032 1,060 1,310 1,403 596
Net Property & Equipment 28 29 20 10 10
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 16,449 16,602 2,078 956 949
Deposits & Other Assets 28 18 7 20 15
Total Assets 17,582 17,755 3,449 2,419 1,603
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 34 46 21 11 8
Current Portion Long-Term Debt 0 43 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 142 178 119 113 89
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 84 66 60 0 0
Total Current Liabilities 260 333 201 124 97
Mortgages 0 0 0 0 0
Deferred Taxes/Income 88 105 23 19 19
Convertible Debt 1,353 1,380 953 948 447
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 12 11 5 10
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,753 1,871 1,218 1,124 603
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 17,017 16,858 2,835 1,880 1,572
Retained Earnings -1,192 -993 -599 -563 -537
Other Equity 5 19 -6 -22 -35
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 15,830 15,884 2,231 1,295 1,000
Total Liabilities & Shareholder's Equity 17,582 17,755 3,449 2,419 1,603
Total Common Equity 15,830 15,884 2,231 1,295 1,000
Shares Outstanding 154.53 144.96 84.30 81.20 74.40
Book Value Per Share 102.44 109.57 26.47 15.95 13.44